Ncic Clinical Trials Group
Clinical trials sponsored by Ncic Clinical Trials Group, explained in plain language.
-
New hope for breast cancer survivors: extended hormone therapy may keep cancer away
Disease control CompletedThis study tested the drug letrozole in over 5,000 women with breast cancer who had already taken tamoxifen for at least 5 years. The goal was to see if letrozole could help prevent the cancer from coming back. Participants took either letrozole or a placebo pill daily. The main …
Phase: PHASE3 • Sponsor: NCIC Clinical Trials Group • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
High-Dose chemo combo shows promise for aggressive breast cancer
Disease control CompletedThis study tested whether giving higher doses of two chemotherapy drugs (epirubicin and docetaxel) along with a drug to boost immune recovery (pegfilgrastim) could safely treat women with locally advanced or inflammatory breast cancer. 93 women took part. The goal was to see how …
Phase: PHASE1, PHASE2 • Sponsor: NCIC Clinical Trials Group • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New cocktail shows promise for Hard-to-Treat lymphoma
Disease control CompletedThis study tested whether adding the drug bortezomib to a standard chemotherapy and antibody combination (BCVP-R) could improve outcomes for people with advanced follicular non-Hodgkin lymphoma who had not yet received treatment. A total of 95 participants were enrolled to see ho…
Phase: PHASE2 • Sponsor: NCIC Clinical Trials Group • Aim: Disease control
Last updated May 11, 2026 20:50 UTC